MHYS News Alert Mass Hysteria Ent (MHYS) 0.0004 09/19/2014 1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mass Hysteria Ent (MHYS) 0.0004 $MHYS

Prosecutors in NYC indict 8 in stock fraud case
By JAKE PEARSON - AP - Thu Sep 11, 5:49PM CDT
NEW YORK (AP) — Four of eight people charged in a penny stock "pump and dump" scheme that defrauded $290 million from thousands of investors were arraigned on Thursday following a two-year investigation.

Keanu Reeves and Ana De Armas to Star in Gee Malik Linton's Dramatic Thriller "Daughter Of God"
ACCESSWIRE - Tue Sep 09, 4:51AM CDT
HOLLYWOOD, CA / ACCESSWIRE / September 9, 2014 / Mass Hysteria Entertainment Company, Inc. (OTC:MHYS)(PINKSHEETS:MHYS) Keanu Reeves and Ana de Armas will star in Gee Malik Linton's dramatic thriller DAUGHTER OF GOD, it was announced today by Fortitude International. Linton wrote the script and is directing the project, which is scheduled to commence principal photography in November. Fortitude represents international rights and company principal Nadine de Barros has kicked-off sales at the 2014 Toronto International Film Festival.

Keanu Reeves and Ana De Armas to Star in Gee Malik Lintons Dramatic Thriller Daughter Of God
eTeligis - Tue Sep 09, 4:31AM CDT
HOLLYWOOD, CA, United States, via ETELIGIS INC., 09/09/2014 - - Mass Hysteria Entertainment Company, Inc. (OTC:MHYS) (PINKSHEETS:MHYS) Keanu Reeves and Ana de Armas will star in Gee Malik Linton's dramatic thriller DAUGHTER OF GOD, it was announced today by Fortitude International. Linton wrote the script and is directing the project, which is scheduled to commence principal photography in November. Fortitude represents international rights and company principal Nadine de Barros has kicked-off sales at the 2014 Toronto International Film Festival.

Mass Hysteria Entertainment Company is Looking for Dynamic Movies to Finance
ACCESSWIRE - Thu Aug 14, 5:27AM CDT
HOLLYWOOD, CA / ACCESSWIRE / August 14, 2014 / Mass Hysteria Entertainment Company, Inc. (OTC Pink: MHYS) (PINKSHEETS: MHYS), under the new brand name of Remark Pictures is actively looking for theatrical motion pictures that are in need of funding. The Company is currently analyzing scripts and packages with recognizable stars and directors in hopes of entering into negotiations shortly to proceed on a couple of projects for the fall. "Remark's mandate is to build a portfolio of dynamic films," said Daniel Grodnik the Company's CEO. "We're interested in film properties at all stages of development and under select circumstances would consider putting up development money. Our search is focused primarily on dramas and thrillers with established marquee names."

Mass Hysteria Entertainment Changes Company Direction and Intends to Rebrand Under the Name Remark Pictures
ACCESSWIRE - Mon Aug 04, 8:56AM CDT
HOLLYWOOD, CA / ACCESSWIRE / August 4, 2014 / Mass Hysteria Entertainment Company, Inc. (OTCQB: MHYS) has changed its' mandate to become a full fledged financier and producer of theatrical movies under the new brand name of REMARK PICTURES. The Company is proceeding with the name change and will seek a new symbol from FINRA. "This change in direction moves the Company from development stage to operational," said the Company's CEO, Daniel Grodnik. "The independent film business today is red hot for quality content and I believe our credentials, experience and access in Hollywood uniquely position us to become a leader in the space."

Mass Hysteria Entertainment Company's Follow Up CEO letter to Shareholders
PR Newswire - Fri Feb 08, 5:30AM CST
Mass Hysteria Entertainment Company, Inc. (MHYS: OTC Markets) provides a follow up letter to its shareholders from its CEO, Daniel Grodnik.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 364

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 157

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 160

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading

Top 5 Most Recently Viewed Articles

Genmab's Ongoing Share Buy-back Program Details and Impact

Updated Category News Views 119

Introduction to the Share Buy-back Program In a recent announcement, Genmab A/S (NASDAQ: GMAB) revealed that it has initiated an ambitious share buy-back program. This initiative aims to repurchase up to 2.2 million shares, which is a strategic step not just to reduce capital but also to fulfill commitments under the Restricted Stock Unit program. The company anticipates...

Continue Reading
Allego Strengthens Leadership with New Innovative CTO

Updated Category News Views 159

Allego Appoints Holger Riemenschneider as Chief Technology Officer Allego N.V. (NASDAQ: ALGO) has recently appointed Holger Riemenschneider as its Chief Technology Officer. This move is a significant step for the company, which has rapidly established itself as a leading name in the electric vehicle (EV) charging industry. With Holger on board, Allego is looking to...

Continue Reading
Exploring the Growth Drivers of Semiconductor Fabrication Software

Updated Category News Views 167

Understanding the Semiconductor Fabrication Software Market The Semiconductor Fabrication Software market is on the brink of significant transformation, with projections indicating a remarkable growth of approximately USD 984.91 million from 2024 to 2028. This growth is primarily fueled by the rising complexity of semiconductor designs in conjunction with the impact of...

Continue Reading
Ohmyhome Prepares to Share Exciting Q3 2024 Growth Insights

Updated Category News Views 45

Ohmyhome Set to Unveil Q3 2024 Growth Insights As a leading property technology platform, Ohmyhome Ltd. (NASDAQ: OMH) has established itself as a prominent player in the real estate market. The company specializes in offering comprehensive solutions ranging from brokerage, renovation, and management services for properties in the region. As consumers increasingly look for...

Continue Reading
Eli Lilly Prepares for Major Breast Cancer Data Presentation

Updated Category News Views 220

Introduction to Eli Lilly's Breast Cancer Initiatives At the upcoming San Antonio Breast Cancer Symposium (SABCS), Eli Lilly and Company (NYSE: LLY) is set to unveil groundbreaking data that enhances its portfolio in breast oncology. The symposium, running from December 9 to 12, serves as a platform for Lilly to highlight advancements in treatments for hormone...

Continue Reading